1. Merck’s Delstrigo and Pifeltro Receives CHMP Approval for the Treatment of HIV-1 Infection in EU

Published: 20 Sep, 2018 |Tags: Merck, Delstrigo, Pifeltro, Receives, CHMP Approval, Treatment, HIV-1 Infection, EU, Regulatory  

2. Sandoz’s Biosimilar Pegfilgrastim Receives CHMP Approval for Febrile Neutropenia

Published: 20 Sep, 2018 |Tags: Sandoz, Biosimilar, Pegfilgrastim, Receives, CHMP Approval, Febrile Neutropenia, EU, Regulatory  

3. Amicus Therapeutics Acquires Worldwide Commercial and Development Rights for Ten Gene Therapy Programs

Published: 20 Sep, 2018 |Tags: Amicus Therapeutics, Acquires, Worldwide, Commercial Development Rights, Ten Gene Therapy Programs, Celenex  

4. Medtronic Acquires Mazor Robotics for $1.64B to Transform Spinal Technologies and Improve Outcomes

Published: 20 Sep, 2018 |Tags: Medtronic, Acquires, Mazor Robotics, $1.64B, Transform Spinal Technologies, Improve Outcomes  

5. Mylan Receives EU Marketing Approval for Adalimumab Biosimilar “Hulio”

Published: 20 Sep, 2018 |Tags: Mylan, Receives, EU Marketing Approval, Adalimumab, Biosimilar, Hulio  

6. Hironic Receives the US FDA Approval for AFit laser acne device to Treat Acne

Published: 18 Sep, 2018 |Tags: Hironic, Receives, the US FDA, Approval, AFit laser acne device, Treat Acne  

7. Ipsen’s Cabometyx Receives Health Canada’s Approval for the Treatment of Advanced Renal Cell Carcinoma (RCC) in Adults

Published: 19 Sep, 2018 |Tags: Ipsen’s Cabometyx Receives Health Canada’s Approval for the Treatment of Advanced Renal Cell Carcinoma (RCC) in Adults

8. Takeda signs a Co-Development Agreement with Molecular Templates for CD38-Targeted Engineered Toxin Bodies(ETBs) for Multiple Myeloma

Published: 19 Sep, 2018 |Tags: Takeda, Co-Development Agreement, Molecular Templates, CD38-Targeted Engineered Toxin Bodies(ETBs), Multiple Myeloma

9. LEO Science & Tech Hub Announces Collaboration with Epicore to Explore the Use of Wearable Sweat Sensors

Published: 19 Sep, 2018 |Tags: LEO Science, TECH Hub, Collaboration, Epicore, Explore, Usage, Wearable, Sweat Sensors  

10. Cancer Genetics Announces Acquisition of NovellusDx to Expand its Oncology Platform

Published: 18 Sep, 2018 |Tags: Cancer Genetics, Announces, Acquisition, NovellusDx, Expand, Oncology Platform, M&A  

11. Novo Nordisk Launches a 24/7 Online Chabot Specifically for People with Diabetes

Published: 18 Sep, 2018 |Tags: Novo Nordisk, Launches, 24/7, Online Chabot, Specifically, Diabetes  

12. Almirall’s Ilumetri Receives EU Approval for the Treatment of Moderate-To-Severe Chronic Plaque Psoriasis in Adults

Published: 18 Sep, 2018 |Tags: Almirall, ILUMETRI, Sun Pharma, Receives, EU Approval, Treatment, Moderate-To-Severe Chronic Plaque Psoriasis, Adults, Dermatology  

13. Cipher Pharmaceuticals Signs Exclusive License Agreement with Moberg Pharma for Commercialization of MOB-015 for Canada

Published: 18 Sep, 2018 |Tags:   Cipher Pharmaceuticals, Exclusive License, Agreement Moberg Pharma, Commercialization, MOB-015, Canada  

14. Pfizer and Atomwise Signs an Evaluation Agreement to Identify Potential Drug for Target Proteins Using AI Technology

Published: 17 Sep, 2018 |Tags: Pfizer, Atomwise, Signs, Evaluation, Agreement, Identify, Potential Drug, Target Proteins Using, AI Technology  

15. AstraZeneca Reports Results of Fasenra in BORA P-III Extension trial for the Treatment of Severe Eosinophilic Asthma

Published: 18 Sep, 2018|Tags: AstraZeneca, Reports, Results, Fasenra, BORA, P-III, Extension trial, Treatment, Severe Eosinophilic Asthma  

16. Leo Pharma and MorphoSys Expands Their Existing Collaboration of Antibody-Based Therapies in Dermatology, to Peptide-Derived Therapeutics

Published: 17 Sep, 2018 |Tag: Leo Pharma, MorphoSys, Expands, Existing, Collaboration, develop and discover, antibody-based therapies, dermatology, peptide-derived therapeutics  

17. Institut Curie Announces formation of Honing Biosciences for the Development of Cell Therapies in Cancer and Chronic Diseases

Published: 13 Sep, 2018 |Tags: Institut Curie, Announces, formation, Honing Biosciences, Development, Cell Therapies Cancer, Chronic Diseases  

18. Teva’s AJOVY Receives FDA Approval for the Treatment of Migraine in Adults with Monthly and Quarterly Dosing

Published: 14 Sep, 2018 |Tags: Teva, AJOVY, Receives, FDA Approval, Treatment Migraine, Adults, Monthly, Quarterly, Dosing, Wholesale Acquisition Cost (WAC)  

19. Allergen Announces Acquisition of Bonti for its Two Aesthetic and Therapeutic Products

Published: 14 Sep, 2018 |Tags: Allergen, Announces, Acquisition, Bonti, Two, Aesthetic, Therapeutic Products